Regional Health Properties, Inc. and SunLink Health Systems, Inc. have jointly announced that shareholders from both companies approved their merger during special meetings held on August 4, 2025. Under the terms of the Amended and Restated Agreement and Plan of Merger dated April 14, 2025, SunLink will merge with and into Regional, with Regional continuing as the surviving entity. In addition, SunLink shareholders gave non-binding advisory approval to the merger-related compensation plan. The completion of the merger is still contingent on meeting the usual closing requirements.
Health Technology Insights: Kelly Roberts Joins CoreCare to Lead AI in Reimbursement
Regional shareholders also approved the issuance of shares of Regional common stock as well as Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares in connection with the merger. Details about the Series D Preferred Stock were disclosed previously in Regional’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on April 18, 2025. These details were also included in Regional’s joint proxy statement and prospectus filed on June 25, 2025, which was supplemented or amended as needed.
This approval marks an important step forward for both companies as they move toward finalizing their merger and combining their resources to strengthen their market presence and operational capabilities.
Health Technology Insights: FCL Names Mike Davis as New CEO to Drive Growth
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
